Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Patient Analgesia After Bloc Serratus (TraumaThorax)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04123977
Recruitment Status : Recruiting
First Posted : October 11, 2019
Last Update Posted : October 21, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:

Thorax traumas are very common in severe traumatology, including road accidents, representing the second most frequent site (after head injury, according to the FIRST study). These thoracic lesions are the cause of many complications (pneumothorax, hemothorax, lung infections, atelectasis).

The national recommendations recommend the use of multi-modal analgesia with the use of regional loco anaesthesia for pain management and prevention of respiratory complications, including infectious complications. The loco-regional anaesthesia of choice is thoracic epidural or paravertebral block, but these techniques are not without risks, and are contraindicated in many situations (severe head trauma, patient under curative anticoagulation, pelvic trauma...).

The anterior Serratus block appears to be a quality localoregional anaesthesia in thoracic surgery, and a few cases in the literature have shown an interest in severe traumatology.

The investigators perform this anterior Serratus block almost systematically in patients with thoracic trauma in the Hautepierre surgical intensive care unit.


Condition or disease
Thorax Traumas

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Evaluation of Patient Analgesia After Bloc Serratus for the Management of Thoracic Trauma
Actual Study Start Date : October 1, 2019
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Retrospective analysis of analgesia after Bloc serratus [ Time Frame: Files analysed retrospectily from January 1st, 2018 to February 28, 2019 will be examined ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient hospitalised in surgical intensive care or continuous trauma care with thorax trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28, 2019
Criteria

Inclusion criteria:

  • Adult patient (≥18 years old)
  • Gender (Male and Female)
  • Patient hospitalised in surgical intensive care or continuous trauma care with thorax trauma who received anterior Serratus block analgesia from January 1, 2018 to February 28, 2019
  • Patient who has given his consent to the reuse of his data for the purposes of this research

Criteria for non-inclusion:

  • Patient who has expressed opposition to participating in the study
  • Impossibility of giving the subject informed information (difficulties in understanding the subject,...)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04123977


Contacts
Layout table for location contacts
Contact: Julien POTTECHER, MD, PhD 33 3 88 12 70 95 julien.pottecher@chru-strasbourg.fr
Contact: Kevin COGNE, MD 33 3.88 12 61 55 kevin.cogne@chru-strasbourg.fr

Locations
Layout table for location information
France
Service de Réanimation chirurgicale_ Hôpital de Hautepierre Recruiting
Strasbourg, France, 67091
Contact: Julien POTTECHER, MD, PhD    33 3 88 12 70 95    julien.pottecher@chru-strasbourg.fr   
Contact: Kevin COGNE, MD    33 3 88 12 61 55    kevin.cogne@chru-strasbourg.fr   
Principal Investigator: Julien POTTECHER, MD, PhD         
Sub-Investigator: Kevin COGNE, MD         
Sub-Investigator: Paul BRUNET, MD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Study Director: Julien POTTECHER, MD, PhD University Hospital, Strasbourg, France

Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT04123977     History of Changes
Other Study ID Numbers: 7406
First Posted: October 11, 2019    Key Record Dates
Last Update Posted: October 21, 2019
Last Verified: October 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
thorax trauma
head injury
Multi-modal analgesia
Paravertebral block
Thoracic epidural
Serratus Block
Additional relevant MeSH terms:
Layout table for MeSH terms
Wounds and Injuries